Back to Search
Start Over
Comprehending fibroblast growth factor receptor like 1: Oncogene or tumor suppressor?
- Source :
- Cancer Treatment and Research Communications, Vol 29, Iss , Pp 100472- (2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- Fibroblast Growth Factor Receptor Like 1 (FGFRL1) signaling has crucial role in a multitude of processes during genetic diseases, embryonic development and various types of cancer. Due to its partial structural similarity with its classical Fibroblast Growth Factor Receptor [FGFR] counterparts and lack of tyrosine kinase domain, FGFRL1 was thought to work as a decoy receptor in FGF/FGFR signaling. Later on, growing number evidences showed that expression of FGFRL1 affects major pathways like ERK1/2, Akt and others, which are dysfunctional in a wide range of human cancers. In this review, we provide an overview of the current understanding of FGFRL1 and its roles in cell differentiation, adhesion and proliferation pathways . Overexpression of FGFRL1 might lead to tumor progression and invasion. In this context, inhibitors for FGFRL1 might have therapeutic benefits in human cancer prognosis.
Details
- Language :
- English
- ISSN :
- 24682942
- Volume :
- 29
- Issue :
- 100472-
- Database :
- Directory of Open Access Journals
- Journal :
- Cancer Treatment and Research Communications
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.106ea49814a746fcbe1be8404c2ffb3c
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.ctarc.2021.100472